Don’t hold animosity for Craig because he’s selling his shares. No Craig Ellins = No GBLX - Craig’s a visionary but he’s not a C Suite manager. He’s built some amazing MMJ/MJ companies but has been incapable of seeing them to fruition. In the meanwhile many of us have made millions of dollars from Craig’s ideas and willingness to take the leap. He’s in his early to mid 70’s and walked away from HIS company for a few million shares. In steps John Poss a lifetime C Suite player and turnaround specialist. Within a year he dumps the old GBLX model, gains control of a 28,000 Sq Ft Fully Licensed Grow Op, A piece of a dispensary for some retail sales. The deals with Kyle Kushman, Kush and Cura and takes us from “pre-revenue” to revenue. If you haven’t seen the facility you’re missing something. Kevin Keuthe has helped build a state of the art facility. Andrea Small Howard has applied and had provisional patents approved. John gets the deal with LSU and the exclusivity that brings and most importantly the most recent $14,000,000.00 cash infusion which will build the facility to maximum capacity, maximum revenue (projected at $18,000,000.00 yearly) and pay for everything were moving towards. A California presence, a Louisiana presence and a strong share of the Las Vegas Recreational Market. All without ANY toxic financing. Obtaining that building and building it out with “clean rooms” that allow us to be a true biopharm takeover target down the road. Most of the float is locked up in strong hands like mine and far wealthier. I’m in it to win it holding a million shares and a million warrants that are worthless unless we hit $.50 - If I didn’t believe we’d get there and beyond I’d sell. The Ruggieri’s are holding about 14,000,000, Pacific Leaf Ventures too. Yes we’re an OTC Company But Rome wasn’t built in a day. The fact that GBLX isn’t a PR machine is a positive. No Pump$D here, we’re building the real deal with a real CEO at the helm. Come February Q4 report and fiscal year end numbers will be impressive and worthy of PR’s. This companies the real deal, patience to February 15 and beyond will bring happy shareholders IMHO.
The above references an opinion and is for information purposes only. It is not intended to be investment advice. Seek a duly licensed professional for investment advice.
AI
